{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T10:34:52Z","timestamp":1770892492852,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["intestinalfailurejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Intestinal Failure"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.intf.2025.100340","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T19:22:02Z","timestamp":1767122522000},"page":"100340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Use of vedolizumab in pediatric intestinal transplant rejection"],"prefix":"10.1016","volume":"9","author":[{"given":"Shahira","family":"Ghobrial","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Moris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Rumbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart S.","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Gondolesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Hyang","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nada","family":"Yazigi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udeme D.","family":"Ekong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas M.","family":"Fishbein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cal S.","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Kroemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intf.2025.100340_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-022-01259-6","article-title":"Targeting integrin pathways: mechanisms and advances in therapy","volume":"8","author":"Pang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"10.1016\/j.intf.2025.100340_bib2","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/s41409-018-0364-5","article-title":"Anti-alpha4beta7 integrin monoclonal antibody (vedolizumab) for the treatment of steroid-resistant severe intestinal acute graft-versus-host disease","volume":"54","author":"Danylesko","year":"2019","journal-title":"Bone Marrow Transpl"},{"issue":"4","key":"10.1016\/j.intf.2025.100340_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.humimm.2024.110810","article-title":"Biologicals in the prevention and treatment of intestinal graft rejection: the state of the art biologicals in intestinal transplantation","volume":"85","author":"Karmi","year":"2024","journal-title":"Hum Immunol"},{"issue":"35","key":"10.1016\/j.intf.2025.100340_bib4","doi-asserted-by":"crossref","first-page":"6385","DOI":"10.3748\/wjg.v23.i35.6385","article-title":"Time to clinical response and remission for therapeutics in inflammatory bowel diseases: what should the clinician expect, what should patients be told?","volume":"23","author":"Vasudevan","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.intf.2025.100340_bib5","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/ajt.16283","article-title":"Rejection of intestinal allotransplants is driven by memory T helper type 17 immunity and responds to infliximab","volume":"21","author":"Kroemer","year":"2021","journal-title":"Am J Transpl"},{"issue":"2","key":"10.1016\/j.intf.2025.100340_bib6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/MOT.0000000000000615","article-title":"The parallel paradigm between intestinal transplant inflammation and inflammatory bowel disease","volume":"24","author":"Belyayev","year":"2019","journal-title":"Curr Opin Organ Transpl"},{"issue":"1","key":"10.1016\/j.intf.2025.100340_bib7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/gutjnl-2014-307127","article-title":"Vedolizumab affects antibody responses to immunisation selectively in the gastrointestinal tract: randomised controlled trial results","volume":"64","author":"Wyant","year":"2015","journal-title":"Gut"},{"issue":"6S2","key":"10.1016\/j.intf.2025.100340_bib8","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1097\/01.tp.0000521457.96829.9e","article-title":"Vedolizumab after intestinal transplantation","volume":"101","author":"Norsa","year":"2017","journal-title":"Transplantation"},{"issue":"6S2","key":"10.1016\/j.intf.2025.100340_bib9","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1097\/01.tp.0000521364.18534.8f","article-title":"Vedolizumab for the treatment of refractory severe rejection in intestinal transplantation","volume":"101","author":"Beduschi","year":"2017","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.intf.2025.100340_bib10","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000000973","article-title":"Safe and successful treatment of acute cellular rejection of an intestine and abdominal wall transplant with vedolizumab","volume":"6","author":"Trentadue","year":"2020","journal-title":"Transpl Direct"},{"issue":"5","key":"10.1016\/j.intf.2025.100340_bib11","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/TP.0000000000003065","article-title":"New insights into the indications for intestinal transplantation: consensus in the year 2019","volume":"104","author":"Kaufman","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.intf.2025.100340_bib12","unstructured":"Based on OPTN data as of August 11, 2025. \u3008https:\/\/optn.transplant.hrsa.gov\/data\/\u3009 [accessed: August 12, 2025]."},{"issue":"3","key":"10.1016\/j.intf.2025.100340_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14756","article-title":"From intestinal failure to transplantation: review on the current need for transplant indications under multidisciplinary transplant programs worldwide","volume":"28","author":"Raghu","year":"2024","journal-title":"Pediatr Transpl"},{"issue":"3","key":"10.1016\/j.intf.2025.100340_bib14","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.gtc.2024.01.002","article-title":"Innate and adaptive immune responses in intestinal transplant rejection: through the lens of inflammatory bowel and intestinal graft-versus-host diseases","volume":"53","author":"Cui","year":"2024","journal-title":"Gastroenterol Clin North Am"},{"issue":"2","key":"10.1016\/j.intf.2025.100340_bib15","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/TP.0000000000001102","article-title":"Intestinal graft failure: should we perform the graft enterectomy before or with retransplantation?","volume":"101","author":"Nagai","year":"2017","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.intf.2025.100340_bib16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1034\/j.1399-3046.2003.00063.x","article-title":"Exfoliative rejection after intestinal transplantation in children","volume":"7","author":"Ishii","year":"2003","journal-title":"Pediatr Transpl"},{"issue":"11","key":"10.1016\/j.intf.2025.100340_bib17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11894-016-0530-0","article-title":"Intestinal transplant inflammation: the third Inflammatory bowel disease","volume":"18","author":"Kroemer","year":"2016","journal-title":"Curr Gastroenterol Rep"},{"issue":"6","key":"10.1016\/j.intf.2025.100340_bib18","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.dld.2022.09.004","article-title":"Prevention of post-operative recurrence of Crohn's disease among patients with prior anti-TNF\u03b1 failure: a retrospective multicenter study","volume":"55","author":"Le Cosquer","year":"2023","journal-title":"Dig Liver Dis"},{"issue":"6","key":"10.1016\/j.intf.2025.100340_bib19","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14654","article-title":"Pneumatosis intestinalis after thoracic organ transplantation in children: a case series and review of the literature","volume":"36","author":"Atwood","year":"2022","journal-title":"Clin Transpl"},{"issue":"5","key":"10.1016\/j.intf.2025.100340_bib20","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/MPG.0000000000003737","article-title":"Pneumatosis intestinalis in children with intestinal failure: the result of intestinal stress from enteral feeding?","volume":"76","author":"Reppucci","year":"2023","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"6","key":"10.1016\/j.intf.2025.100340_bib21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/2047-783X-14-6-231","article-title":"Natural history, clinical pattern, and surgical considerations of pneumatosis intestinalis","volume":"14","author":"Khalil","year":"2009","journal-title":"Eur J Med Res"},{"issue":"1","key":"10.1016\/j.intf.2025.100340_bib22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.6002\/ect.MESOT2018.L32","article-title":"Update on chronic rejection after intestinal transplant: an overview from experimental settings to clinical outcome","volume":"17","author":"Lauro","year":"2019","journal-title":"Exp Clin Transpl"},{"issue":"2","key":"10.1016\/j.intf.2025.100340_bib23","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/0148607117701696","article-title":"Meeting report of the XIV International small bowel transplant symposium: summary of presentations, workshops, and debates from a comprehensive meeting on intestinal failure, rehabilitation, and transplantation, Buenos Aires, Argentina, June 10\u201313, 2015","volume":"42","author":"Gondolesi","year":"2018","journal-title":"JPEN J Parent Enter Nutr"},{"key":"10.1016\/j.intf.2025.100340_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105028","article-title":"Dynamic establishment of recipient resident memory T cell repertoire after human intestinal transplantation","volume":"101","author":"Jiao","year":"2024","journal-title":"EBioMedicine"},{"issue":"8","key":"10.1016\/j.intf.2025.100340_bib25","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1038\/s41591-024-03016-4","article-title":"Vedolizumab for the prevention of intestinal acute GVHD after allogeneic hematopoietic stem cell transplantation: a randomized phase 3 trial","volume":"30","author":"Chen","year":"2024","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.intf.2025.100340_bib26","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.transproceed.2024.11.021","article-title":"Chronic graft enteropathy treated with vedolizumab: a case report","volume":"57","author":"Trentadue","year":"2025","journal-title":"Transpl Proc"}],"container-title":["Intestinal Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950456225003057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950456225003057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T09:44:19Z","timestamp":1770889459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950456225003057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":26,"alternative-id":["S2950456225003057"],"URL":"https:\/\/doi.org\/10.1016\/j.intf.2025.100340","relation":{},"ISSN":["2950-4562"],"issn-type":[{"value":"2950-4562","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of vedolizumab in pediatric intestinal transplant rejection","name":"articletitle","label":"Article Title"},{"value":"Intestinal Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intf.2025.100340","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of International Intestinal Rehabilitation & Transplant Association.","name":"copyright","label":"Copyright"}],"article-number":"100340"}}